more news >>

Latest Clinical Trials


more insights >>

Patient Perspectives

more columns >>

Pompe Disease Features

more features >>

Rare Care Podcast

Barry Byrne, MD, director of the University of Florida’s Powell Gene Therapy Center in Gainesville, has spent years researching potential gene therapies for Pompe disease. In this edition of the Rare Care podcast, Dr. Byrne comments on the FDA’s recent approval of avalglucosidase alfa-ngpt (Nexviazyme) to treat Pompe, as well the future of gene therapies in treating the disease.